PATENT CLAIM ANALYSIS

Application Number: 16061369
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["514", "081000"]

Abstract:
The present invention relates to spirocyclic quinolizine derivatives and pharmaceutically acceptable salts or prodrug thereof, compositions comprising at least one spirocyclic quinolizine derivative, and methods of using the spirocyclic quinolizine derivatives for treating or preventing HIV infection in a subject.

Claim (Index 6):
The compound of  claim 1 , wherein A is \u2014NHC(O)\u2014, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15560896', '15775871', '15575433', '15775966', '14652580']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092991247359759
- 35 USC 102 Novelty (BERT): 0.5794643838528685
- Combined Prediction Score: 0.7863156506476652
- Mean Citation Score: 442.889044
- Max Citation Score: 454.46243
- Similarity Product: 434.9938536333955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test